Corcept Therapeutics Incorporated logo CORT - Corcept Therapeutics Incorporated

NEXT EARNINGS: Feb 25, 2026 (in 21 days)
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 9
SELL 2
STRONG
SELL
0
| PRICE TARGET: $76.00 DETAILS
HIGH: $105.00
LOW: $30.00
MEDIAN: $95.00
CONSENSUS: $76.00
UPSIDE: 91.58%
Market Cap: 4.17B
Volume: 530,156
Avg Volume: 1,811,620
52 Week Range: 32.99-117.33
Sector: Healthcare
Industry: Biotechnology
Beta: 0.26
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 500
IPO Date: 2004-04-14
EPS (TTM): 1.35
P/E Ratio: 37.23
Revenue (TTM): 675.04M
Total Assets: 840.55M
Total Debt: 6.94M
Cash & Equiv: 127.67M
Rev Growth (5Y): 17.1%
EPS Growth (5Y): 10.5%
FCF Growth (5Y): 7.7%
ROCE: 19.6%
Debt/Equity: 0.01

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 675.04M 482.38M 401.86M 365.98M 353.87M 306.49M 251.25M 159.20M 81.32M 50.29M 26.55M 10.36M
Net Income 139.73M 106.14M 101.42M 112.51M 106.01M 94.18M 75.41M 129.12M 8.14M (6.41M) (31.38M) (46.01M)
EPS 1.35 1.02 0.95 0.97 0.92 0.82 0.60 1.14 0.07 -0.06 -0.31 -0.46
Total Assets 840.55M 621.52M 583.43M 423.76M 571.73M 412.31M 311.69M 220.54M 68.75M 51.94M 34.63M 63.08M
Total Debt 6.94M 151,000 1.14M 526,000 2.55M 3.46M N/A N/A 14.66M 14.96M 9.42M 5.74M
Cash & Equivalents 127.67M 135.55M 66.33M 77.62M 76.19M 31.27M 206.76M 104.03M 51.54M 40.44M 24.25M 54.88M
Operating Cash Flow 198.07M 127.04M 120.32M 167.89M 151.97M 136.12M 115.67M 60.94M 18.39M 3.13M (27.38M) (37.06M)
Free Cash Flow 195.90M 126.90M 119.91M 167.42M 150.73M 135.03M 115.37M 60.52M 18.20M 3.11M (27.55M) (37.19M)
FCF per Share 1.90 1.23 1.12 1.45 1.31 1.18 0.92 0.53 0.16 0.03 -0.27 -0.37
Book Value 679.59M 506.70M 501.84M 375.81M 523.34M 371.18M 275.88M 190.97M 41.38M 18.50M (3.39M) 21.02M
Cash & ST Investments 383.33M 368.22M 431.67M 223.53M 440.70M 275.96M 206.76M 104.03M 51.54M 40.44M 24.25M 54.88M
ROC Equity 0.21 0.21 0.20 0.30 0.20 0.25 0.27 0.68 0.20 -0.35 N/A -2.19